Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001331231 | SCV001523224 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 12 | 2020-03-11 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001863239 | SCV002178522 | uncertain significance | not provided | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid with glycine at codon 124 of the CDH23 protein (p.Asp124Gly). The aspartic acid residue is highly conserved and there is a moderate physicochemical difference between aspartic acid and glycine. This variant is present in population databases (rs751192273, ExAC 0.001%). This missense change has been observed in individual(s) with non-syndromic deafness (PMID: 12075507). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |